WASHINGTON - The United States Drug Enforcement (DEA) this week kicks off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort. The National Red Ribbon Campaign began after drug traffickers in Mexico tortured and brutally murdered Special Agent Enrique “Kiki” Camarena in March 1985. Officially, Red Ribbon Week...

WASHINGTON - The United States Drug Enforcement (DEA) has reduced the amount of almost every Schedule II opiate and opioid medication that may be manufactured in the United States in 2017 by 25 percent or more, according to a being published in the Federal Register tomorrow and available for public...

WASHINGTON - In an effort to prevent drug use while educating youth, the National Family (NFP), invites families and schools across America to participate in its 6th Annual National Red Ribbon Week Photo Contest. The contest, which is co-sponsored by the Drug Enforcement (DEA), will be held in conjunction with...

WASHINGTON - This week the heads of the national drug-control agencies for the United States and the People’s Republic of China, Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and Director (DG) Hu Minglang from the Narcotics Control (NCB) of the Ministry of Public Security, met at DEA Headquarters in Arlington...

WASHINGTON - DEA has issued a public warning to the public and law enforcement nationwide about the health and safety risks of carfentanil. Carfentanil is a synthetic opioid that is 10,000 times more potent than morphine and 100 times more potent than fentanyl, which itself is 50 times more potent...

WASHINGTON - The Drug Enforcement (DEA) today announced its intention to place the active materials in the kratom plant into Schedule I of the Controlled Substances Act in order to avoid an imminent hazard to public safety. Mitragynine and 7-hydroxymitragynine are found in kratom, which is a tropical tree indigenous...

WASHINGTON - The Drug Enforcement (DEA) announced several marijuana- related actions, including actions regarding scientific research and scheduling of marijuana, as well as principles on the cultivation of industrial hemp under the Agricultural Act of 2014. DEA Publishes Responses to Two Pending Petitions to Reschedule Marijuana - DEA has denied...

WASHINGTON - Hundreds of thousands of counterfeit prescription pills, many containing deadly amounts of fentanyl and fentanyl-related compounds, have made their way into the U.S. drug market, according to a DEA intelligence report released today. Law enforcement nationwide report higher fentanyl availability, seizures, and known overdose deaths than at any...

WASHINGTON - The United States Drug Enforcement (DEA) released the 2016 National Heroin Threat Assessment Summary - (NHTA) today. The report outlines the expanding public health crisis afflicting America due to the use and abuse of heroin and other opioid drugs. Some key facts: The number of people reporting current...

WASHINGTON - Americans turned in more unused prescription drugs at the most recent DEA National Prescription Drug Take-Back Day than on any of the previous 10 events since it began in 2010, demonstrating their understanding of the value of this service. Last weekend the DEA and over 4,200 of its...